SCHEMBL14587409

SCHEMBL14587409

CC(=O)N1C(=O)O[C@H](C)[C@@H]1c1ccc(F)c(F)c1

nearest known ligand 0.52

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ADRA1A P35348 5/20 0.52
ADRA1B P35368 5/20 0.52
ADRA1D P25100 4/20 0.52
HRH1 P35367 1/20 0.52
IDO1 P14902 2/20 0.33
TDO2 P48775 2/20 0.33
HTR7 P34969 1/20 0.32
HCAR3 P49019 1/20 0.32
HCAR2 Q8TDS4 1/20 0.32
ADAMTS5 Q9UNA0 2/20 0.31
ELANE P08246 1/20 0.31
KDM1A O60341 3/20 0.31
GRM2 Q14416 1/20 0.31
ATM Q13315 1/20 0.31
KDM4E B2RXH2 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31
CES2 O00748 1/20 0.31
CES1 P23141 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6082094 0.89 ADRA1A (0.52) ADRA1AADRA1BADRA1DHRH1IDO1
SCHEMBL7095750 0.89 ADRA1A (0.52) ADRA1AADRA1BADRA1DHRH1IDO1
SCHEMBL6959819 0.89 ADRA1A (0.52) ADRA1AADRA1BADRA1DHRH1IDO1
SCHEMBL5658840 0.75 ADRA1A (0.42) ADRA1AADRA1BADRA1DHRH1KDM1A
SCHEMBL5662288 0.75 ADRA1A (0.42) ADRA1AADRA1BADRA1DHRH1KDM1A
SCHEMBL8174001 0.75 ADRA1A (0.42) ADRA1AADRA1BADRA1DHRH1KDM1A
SCHEMBL7075810 0.71 ADRA1A (0.40) ADRA1AADRA1BADRA1DHRH1IDO1
SCHEMBL7083169 0.71 ADRA1A (0.40) ADRA1AADRA1BADRA1DHRH1IDO1
SCHEMBL14587408 0.71 HCAR3 (0.36) ADRA1AADRA1BADRA1DHRH1HTR7
SCHEMBL7083166 0.71 ADRA1A (0.40) ADRA1AADRA1BADRA1DHRH1IDO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070043080-A1 Substituted anilinic piperidines as MCH selective antagonists MARZABADI MOHAMMAD R 2007-02-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070043080-A1 Substituted anilinic piperidines as MCH selective antagonists MCHR1, MCHR2, MC1R ADRA1A 46/4885ADRA1B 56/4885ADRA1D 48/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.